logo

For the Inventor, By the Inventor

Ghent, Belgium

Maurits E Vandewalle

This inventor holds 9 USPTO granted patents and 2 EPO patents. Top assignees: K.u. Leuven Research & Development, University of Ghent, Duphar International Research Bv. Active years: 1985-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maurits E Vandewalle. Retrieved from https://idiyas.com/inventor/maurits-e-vandewalle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 66.7


Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 34(Granted Patents)


Location History:

  • Gent, BE (1985 - 2011)
  • Ghent, BE (2000 - 2012)

Company Filing History:

goldMedal3 out of 84 
 
K.u. Leuven Research & Development
 patents
silverMedal3 out of 505 
 
University of Ghent
 patents
bronzeMedal2 out of 169 
 
Duphar International Research Bv
 patents
4. 2 out of 7 
 
Laboratoire Theramex S.a.
 patents
5. 1 out of 3 
 
Ire-Medgenix S.a.
 patents
6. 1 out of 16 
 
Laboratoire Theramex
 patents
where one patent can have more than one assignee

Years Active: 1985-2012

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 8258126 - [object Object] (2012-09-04),
2. 7888338 - 7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes (2011-02-15),
3. 7704986 - [object Object] (2010-04-27),
4. 6548715 - Structural analogues of vitamin D (2003-04-15),
5. 6191292 - Precursors of the A-ring of vitamin D and method and intermediates for the preparation thereof (2001-02-20),
6. 6017907 - Structural analogues of vitamin D (2000-01-25),
7. 5162335 - Di- and tetrahydroisoquinoline derivatives (1992-11-10),
8. 5093519 - Vitamin D derivatives: therapeutic applications and applications to (1992-03-03),
9. 4539153 - Method of preparing 1 .alpha.-hydroxyvitamin D and 1 (1985-09-03),

Title: Inventor Maurits E Vandewalle: Innovating in Pharmaceutical Chemistry

Introduction

Maurits E Vandewalle, an esteemed inventor based in Gent, Belgium, has made significant contributions to the field of pharmaceutical chemistry. With a portfolio that boasts nine patents, Vandewalle's innovations focus on advancing medical treatments, particularly for bone disorders.

Latest Patents

Among his latest patents, Vandewalle has developed novel vitamin D analogues that are particularly useful for creating pharmaceutical compositions aimed at preventing or treating bone disorders such as osteoporosis. Another notable invention involves 7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes, which encompasses not only the compound but also the compositions that include it and methods for treating various diseases and illnesses through its application.

Career Highlights

Vandewalle's professional journey includes significant roles at K.U. Leuven Research & Development and Universiteit Gent. His research and innovations have garnered attention in both academic and professional circles, underscoring his dedication to enhancing human health through scientific discovery.

Collaborations

Throughout his career, Vandewalle has collaborated with esteemed colleagues such as Roger Bouillon and Pierre Jean De Clercq. These partnerships have enriched his work and fostered a conducive environment for groundbreaking research and development.

Conclusion

Maurits E Vandewalle's contributions to the field of pharmaceutical chemistry exemplify the impact that dedicated inventors can have on healthcare innovation. His patented inventions reflect not only his expertise but also his commitment to addressing critical health issues, paving the way for advancements that benefit countless individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…